+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cat Medicines Market by Therapeutic Area, Product Type, Route of Administration, End User - Global Forecast to 2030- Product Image
Cat Medicines Market by Therapeutic Area, Product Type, Route of Administration, End User - Global Forecast to 2030- Product Image
Sale

Cat Medicines Market by Therapeutic Area, Product Type, Route of Administration, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011229
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cat Medicines Market grew from USD 16.12 billion in 2024 to USD 17.19 billion in 2025. It is expected to continue growing at a CAGR of 6.54%, reaching USD 23.58 billion by 2030.

Unveiling the Landscape of Cat Therapeutics

The global landscape of cat medicines has evolved dramatically over the past decade, driven by a convergence of scientific breakthroughs, shifting pet ownership dynamics, and heightened emphasis on feline wellness. Once considered a niche sector within veterinary pharmaceuticals, the market for cat therapeutics now encompasses a diverse array of treatment modalities, ranging from antibiotics and anti-inflammatories to endocrinological supports and advanced vaccines. This expansion reflects both the maturity of veterinary research infrastructure and the growing recognition of cats as integral members of households worldwide.

As veterinary professionals increasingly adopt a proactive stance toward preventive care, owners seek evidence-based solutions to address chronic conditions, manage pain, and safeguard against infectious diseases. Parallel to this demand, regulatory agencies have refined guidelines to enhance drug safety and efficacy, while manufacturing innovations have optimized delivery mechanisms for improved compliance. In this context, stakeholders require a nuanced overview of market drivers, emerging trends, and critical inflection points. This executive summary distills key insights from comprehensive primary and secondary research, establishing a foundational understanding for decision-makers aiming to leverage the growth trajectory of cat medicines.

Navigating Industry Transformations Shaping Cat Care

Over the last few years, the cat medicines sector has experienced transformative shifts that redefine competitive dynamics and patient outcomes alike. Innovations in molecular biology have led to more targeted anti-infective therapies, reducing off-target effects and accelerating recovery times. Concurrently, advancements in drug formulation have expanded the availability of user-friendly topical treatments, enabling pet owners to administer care with greater confidence and consistency.

Beyond technological breakthroughs, the market has also been reshaped by evolving consumer behavior. Increasingly, pet owners prioritize holistic wellness approaches, seeking integrative solutions that complement traditional pharmaceuticals with nutritional supplements and behavior-modifying interventions. At the same time, digital health platforms are revolutionizing remote diagnostics and telemedicine, facilitating early detection of endocrine disorders and chronic inflammatory conditions. These combined factors have fostered an environment in which agility and innovation dictate market leadership, underscoring the importance of adaptive R&D strategies and robust stakeholder engagement.

Assessing the 2025 United States Tariff Impact on Feline Medications

In 2025, newly implemented United States tariffs have exerted a pronounced impact on the supply chain and pricing frameworks for feline medications. Raw materials sourced internationally now incur additional duties, translating into elevated production costs for injectable antibiotics, anti-inflammatories, and specialty endocrine treatments. Manufacturers have responded by reevaluating sourcing strategies, with some diversifying ingredient procurement across multiple geographies to mitigate tariff exposure and sustain margin integrity.

These adjustments have rippled through distribution channels, as wholesalers and veterinary clinics navigate price escalations and negotiate revised contracts. Although end-user price increases remain modest in the short term, prolonged tariff burdens may catalyze consolidation among smaller producers facing cost pressures. Meanwhile, therapeutic segments reliant on high-purity reagents, such as insulin analogs and advanced vaccines, are particularly susceptible to supply constraints. Stakeholders must therefore prioritize supply chain resilience, explore tariff relief measures, and invest in local manufacturing capabilities to preserve market stability and ensure uninterrupted access to vital feline treatments.

Decoding Market Segmentation for Targeted Medicine Strategies

A granular view of the market emerges when parsing therapeutic categories and product typologies. Within anesthetics, the bifurcation between general and local agents reveals divergent adoption rates, driven by procedural complexity and recovery time considerations. Injectable antibiotics-both intravenous and oral-remain indispensable for acute infection management, while solid dosage NSAIDs and steroid formulations address chronic inflammatory conditions with distinct pharmacokinetic profiles. Endocrine interventions encompass both insulin therapies and thyroid hormone analogs, each tailored to address specific metabolic imbalances in aging felines.

Product form factors further influence prescribing behaviors: intramuscular and subcutaneous injectables deliver rapid onset, whereas oral solutions and tablets offer convenience for long-term management. Topical products, ranging from spot-on treatments to medicated shampoos, furnish frontline defenses against parasites without systemic exposure. Administration routes intertwine with these categories, as liquid oral options compete with transdermal patches and local topical treatments for owner acceptance. Finally, end users span inquisitive pet owners seeking over-the-counter wellness remedies and veterinary professionals operating in clinic and hospital environments, each demanding different levels of clinical support and training.

Examining Regional Dynamics Influencing Cat Medicines Demand

Regional nuances exert a profound influence on demand patterns and competitive positioning within the cat medicines sector. In the Americas, high pet ownership rates and mature veterinary infrastructures drive robust uptake of advanced therapeutics, particularly in anti-infective and endocrine segments. Market participants prioritize regulatory compliance and value-added services to differentiate themselves in this sophisticated landscape.

Across Europe, Middle East & Africa, fragmentation remains a defining characteristic, with regulatory mosaics and variable economic conditions shaping access to both branded and generic offerings. Local manufacturing partnerships and targeted outreach initiatives serve as critical levers to expand market penetration. Meanwhile, the Asia-Pacific region exhibits the fastest growth trajectory, propelled by rising disposable incomes, burgeoning pet adoption trends, and progressive policy frameworks supporting animal health. Stakeholders in this region focus on cost-effective product innovation and scalable distribution networks to capture emerging segments.

Spotlight on Leading Innovators Driving Feline Health Solutions

Several key players command a significant share of the cat medicines market, distinguished by their depth of product portfolios and commitment to R&D investment. Leading pharmaceutical firms leverage advanced formulation technologies to extend patent life cycles for critical drugs such as insulin analogs and long-acting anti-inflammatories. At the same time, niche biotechnology companies introduce novel parasiticide complexes and recombinant vaccine platforms, challenging incumbents with targeted efficacy and streamlined manufacturing processes.

Collaborative ventures between multinational corporations and specialized research institutes have accelerated the translation of genomic insights into tailored therapies for hereditary disorders. Strategic acquisitions have further consolidated capabilities in injectables and topical solutions, while licensing partnerships facilitate geographic expansion. As competition intensifies, companies with agile development pipelines and integrated commercialization strategies will be best positioned to capture shifting demand and reinforce their leadership in the feline therapeutics arena.

Strategic Imperatives to Seize Growth and Improve Outcomes

Industry leaders must adopt a multifaceted approach to capitalize on emerging opportunities and fortify market positions. Prioritizing investment in dual-purpose platforms that accommodate both small-molecule anti-infectives and biologics will yield synergistic benefits across therapeutic areas. Similarly, expanding modular manufacturing facilities capable of rapid scale-up can mitigate tariff impacts and ensure responsive supply chains.

Engagement with veterinary professionals through continuing education programs and digital training modules will enhance product adoption, particularly for complex endocrine therapies requiring precise dosing regimens. In parallel, forging alliances with pet care ecosystems-spanning wellness apps to telehealth providers-will foster integrated care pathways and deepen customer loyalty. Finally, executives should monitor regulatory developments closely to anticipate policy shifts, pursue expedited approvals for niche indications, and align portfolio strategies with evolving animal welfare standards.

Methodological Rigor Underpinning Our Research Findings

Our findings derive from a rigorous, multi-phased research design combining quantitative data analysis with qualitative expert interviews. The process commenced with an exhaustive review of peer-reviewed journals, regulatory filings, and proprietary patent databases to establish a robust baseline of scientific and market intelligence. Subsequent primary research involved structured discussions with veterinarians, pharmaceutical executives, and supply chain specialists to validate trends and uncover latent demand drivers.

Advanced statistical modeling was applied to dissect pricing fluctuations and forecast scenario-based tariff impacts, while competitive benchmarking evaluated relative positioning across product segments. Quality control protocols ensured data integrity at every stage, with cross-validation against third-party syndicated sources reinforcing the reliability of conclusions. This triangulated methodology yields a comprehensive view of the cat medicines landscape, equipping stakeholders with actionable insights anchored in empirical evidence.

Synthesizing Insights to Propel Future Progress

As the cat medicines market continues its dynamic evolution, stakeholders equipped with deep segmentation insights, regional understanding, and strategic foresight will lead the charge toward improved feline health outcomes. The convergence of technological innovation, regulatory adaptation, and shifting consumer preferences underscores the importance of agility and informed decision-making.

By synthesizing market drivers, tariff implications, and competitive dynamics, this executive summary offers a roadmap for navigating complexities and capitalizing on growth catalysts. Whether refining R&D pipelines, optimizing supply chains, or enhancing stakeholder engagement, decision-makers can leverage these insights to strengthen resilience and achieve sustainable expansion. The future of feline therapeutics depends on a proactive stance that blends scientific excellence with market savvy, ensuring that pet cats worldwide benefit from safer, more effective treatments.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Therapeutic Area
    • Anesthetics
      • General
      • Local
    • Anti-Infectives
      • Injectable Antibiotics
      • Oral Antibiotics
    • Anti-Inflammatories
      • NSAIDs
      • Steroids
    • Endocrine
      • Insulin
      • Thyroid
    • Parasiticides
      • Injectable
      • Oral
      • Topical
    • Vaccines
      • Inactivated
      • Live
  • Product Type
    • Injectable Products
      • Intramuscular
      • Intravenous
      • Subcutaneous
    • Liquid Dosage Forms
      • Oral Solutions
      • Suspensions
      • Syrups
    • Solid Dosage Forms
      • Capsules
      • Powders
      • Tablets
    • Topical Products
      • Ointments
      • Shampoos
      • Spot-On Treatments
  • Route Of Administration
    • Oral
      • Liquid Oral
      • Solid Oral
    • Parenteral
      • Intramuscular
      • Intravenous
      • Subcutaneous
    • Topical
      • Local Topical
      • Transdermal
  • End User
    • Pet Owners
    • Veterinary Professionals
      • Hospital Clinics
      • Private Practices
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Zoetis Inc.
  • Boehringer Ingelheim International GmbH
  • Merck & Co., Inc.
  • Elanco Animal Health Incorporated
  • Ceva Santé Animale S.A.
  • Virbac S.A.
  • Vetoquinol S.A.
  • Dechra Pharmaceuticals PLC
  • Phibro Animal Health Corporation
  • Heska Corporation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cat Medicines Market, by Therapeutic Area
8.1. Introduction
8.2. Anesthetics
8.2.1. General
8.2.2. Local
8.3. Anti-Infectives
8.3.1. Injectable Antibiotics
8.3.2. Oral Antibiotics
8.4. Anti-Inflammatories
8.4.1. NSAIDs
8.4.2. Steroids
8.5. Endocrine
8.5.1. Insulin
8.5.2. Thyroid
8.6. Parasiticides
8.6.1. Injectable
8.6.2. Oral
8.6.3. Topical
8.7. Vaccines
8.7.1. Inactivated
8.7.2. Live
9. Cat Medicines Market, by Product Type
9.1. Introduction
9.2. Injectable Products
9.2.1. Intramuscular
9.2.2. Intravenous
9.2.3. Subcutaneous
9.3. Liquid Dosage Forms
9.3.1. Oral Solutions
9.3.2. Suspensions
9.3.3. Syrups
9.4. Solid Dosage Forms
9.4.1. Capsules
9.4.2. Powders
9.4.3. Tablets
9.5. Topical Products
9.5.1. Ointments
9.5.2. Shampoos
9.5.3. Spot-On Treatments
10. Cat Medicines Market, by Route of Administration
10.1. Introduction
10.2. Oral
10.2.1. Liquid Oral
10.2.2. Solid Oral
10.3. Parenteral
10.3.1. Intramuscular
10.3.2. Intravenous
10.3.3. Subcutaneous
10.4. Topical
10.4.1. Local Topical
10.4.2. Transdermal
11. Cat Medicines Market, by End User
11.1. Introduction
11.2. Pet Owners
11.3. Veterinary Professionals
11.3.1. Hospital Clinics
11.3.2. Private Practices
12. Americas Cat Medicines Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Cat Medicines Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Cat Medicines Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Zoetis Inc.
15.3.2. Boehringer Ingelheim International GmbH
15.3.3. Merck & Co., Inc.
15.3.4. Elanco Animal Health Incorporated
15.3.5. Ceva Santé Animale S.A.
15.3.6. Virbac S.A.
15.3.7. Vetoquinol S.A.
15.3.8. Dechra Pharmaceuticals PLC
15.3.9. Phibro Animal Health Corporation
15.3.10. Heska Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CAT MEDICINES MARKET MULTI-CURRENCY
FIGURE 2. CAT MEDICINES MARKET MULTI-LANGUAGE
FIGURE 3. CAT MEDICINES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CAT MEDICINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CAT MEDICINES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CAT MEDICINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CAT MEDICINES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CAT MEDICINES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CAT MEDICINES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CAT MEDICINES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CAT MEDICINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CAT MEDICINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CAT MEDICINES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CAT MEDICINES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CAT MEDICINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CAT MEDICINES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CAT MEDICINES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CAT MEDICINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CAT MEDICINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CAT MEDICINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CAT MEDICINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CAT MEDICINES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CAT MEDICINES MARKET SIZE, BY ANESTHETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CAT MEDICINES MARKET SIZE, BY GENERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CAT MEDICINES MARKET SIZE, BY LOCAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CAT MEDICINES MARKET SIZE, BY ANESTHETICS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CAT MEDICINES MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CAT MEDICINES MARKET SIZE, BY INJECTABLE ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CAT MEDICINES MARKET SIZE, BY ORAL ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CAT MEDICINES MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CAT MEDICINES MARKET SIZE, BY ANTI-INFLAMMATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CAT MEDICINES MARKET SIZE, BY NSAIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CAT MEDICINES MARKET SIZE, BY STEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CAT MEDICINES MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CAT MEDICINES MARKET SIZE, BY ENDOCRINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CAT MEDICINES MARKET SIZE, BY INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CAT MEDICINES MARKET SIZE, BY THYROID, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CAT MEDICINES MARKET SIZE, BY ENDOCRINE, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CAT MEDICINES MARKET SIZE, BY PARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CAT MEDICINES MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CAT MEDICINES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CAT MEDICINES MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CAT MEDICINES MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CAT MEDICINES MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CAT MEDICINES MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CAT MEDICINES MARKET SIZE, BY LIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CAT MEDICINES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CAT MEDICINES MARKET SIZE, BY INJECTABLE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CAT MEDICINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CAT MEDICINES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CAT MEDICINES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CAT MEDICINES MARKET SIZE, BY INJECTABLE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CAT MEDICINES MARKET SIZE, BY LIQUID DOSAGE FORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CAT MEDICINES MARKET SIZE, BY ORAL SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CAT MEDICINES MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CAT MEDICINES MARKET SIZE, BY SYRUPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CAT MEDICINES MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CAT MEDICINES MARKET SIZE, BY SOLID DOSAGE FORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CAT MEDICINES MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CAT MEDICINES MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CAT MEDICINES MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CAT MEDICINES MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CAT MEDICINES MARKET SIZE, BY TOPICAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CAT MEDICINES MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CAT MEDICINES MARKET SIZE, BY SHAMPOOS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CAT MEDICINES MARKET SIZE, BY SPOT-ON TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CAT MEDICINES MARKET SIZE, BY TOPICAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CAT MEDICINES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CAT MEDICINES MARKET SIZE, BY LIQUID ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CAT MEDICINES MARKET SIZE, BY SOLID ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CAT MEDICINES MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CAT MEDICINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CAT MEDICINES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CAT MEDICINES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CAT MEDICINES MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CAT MEDICINES MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL CAT MEDICINES MARKET SIZE, BY LOCAL TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL CAT MEDICINES MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL CAT MEDICINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL CAT MEDICINES MARKET SIZE, BY PET OWNERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL CAT MEDICINES MARKET SIZE, BY VETERINARY PROFESSIONALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL CAT MEDICINES MARKET SIZE, BY HOSPITAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL CAT MEDICINES MARKET SIZE, BY PRIVATE PRACTICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL CAT MEDICINES MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS CAT MEDICINES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS CAT MEDICINES MARKET SIZE, BY ANESTHETICS, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS CAT MEDICINES MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS CAT MEDICINES MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS CAT MEDICINES MARKET SIZE, BY ENDOCRINE, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS CAT MEDICINES MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS CAT MEDICINES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS CAT MEDICINES MARKET SIZE, BY INJECTABLE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS CAT MEDICINES MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS CAT MEDICINES MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS CAT MEDICINES MARKET SIZE, BY TOPICAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS CAT MEDICINES MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS CAT MEDICINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS CAT MEDICINES MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS CAT MEDICINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES CAT MEDICINES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES CAT MEDICINES MARKET SIZE, BY ANESTHETICS, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES CAT MEDICINES MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES CAT MEDICINES MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES CAT MEDICINES MARKET SIZE, BY ENDOCRINE, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES CAT MEDICINES MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES CAT MEDICINES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES CAT MEDICINES MARKET SIZE, BY INJECTABLE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES CAT MEDICINES MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES CAT MEDICINES MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES CAT MEDICINES MARKET SIZE, BY TOPICAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES CAT MEDICINES MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES CAT MEDICINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES CAT MEDICINES MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES CAT MEDICINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 111. CANADA CAT MEDICINES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 112. CANADA CAT MEDICINES MARKET SIZE, BY ANESTHETICS, 2018-2030 (USD MILLION)
TABLE 113. CANADA CAT MEDICINES MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 114. CANADA CAT MEDICINES MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 115. CANADA CAT MEDICINES MARKET SIZE, BY ENDOCRINE, 2018-2030 (USD MILLION)
TABLE 116. CANADA CAT MEDICINES MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 117. CANADA CAT MEDICINES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 118. CANADA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. CANADA CAT MEDICINES MARKET SIZE, BY INJECTABLE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 120. CANADA CAT MEDICINES MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 121. CANADA CAT MEDICINES MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 122. CANADA CAT MEDICINES MARKET SIZE, BY TOPICAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 123. CANADA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 124. CANADA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 125. CANADA CAT MEDICINES MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 126. CANADA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 127. CANADA CAT MEDICINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. CANADA CAT MEDICINES MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 129. MEXICO CAT MEDICINES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 130. MEXICO CAT MEDICINES MARKET SIZE, BY ANESTHETICS, 2018-2030 (USD MILLION)
TABLE 131. MEXICO CAT MEDICINES MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 132. MEXICO CAT MEDICINES MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 133. MEXICO CAT MEDICINES MARKET SIZE, BY ENDOCRINE, 2018-2030 (USD MILLION)
TABLE 134. MEXICO CAT MEDICINES MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 135. MEXICO CAT MEDICINES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 136. MEXICO CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. MEXICO CAT MEDICINES MARKET SIZE, BY INJECTABLE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 138. MEXICO CAT MEDICINES MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 139. MEXICO CAT MEDICINES MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 140. MEXICO CAT MEDICINES MARKET SIZE, BY TOPICAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 141. MEXICO CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 142. MEXICO CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 143. MEXICO CAT MEDICINES MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 144. MEXICO CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 145. MEXICO CAT MEDICINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. MEXICO CAT MEDICINES MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL CAT MEDICINES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL CAT MEDICINES MARKET SIZE, BY ANESTHETICS, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL CAT MEDICINES MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL CAT MEDICINES MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL CAT MEDICINES MARKET SIZE, BY ENDOCRINE, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL CAT MEDICINES MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL CAT MEDICINES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL CAT MEDICINES MARKET SIZE, BY INJECTABLE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL CAT MEDICINES MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL CAT MEDICINES MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL CAT MEDICINES MARKET SIZE, BY TOPICAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL CAT MEDICINES MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL CAT MEDICINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL CAT MEDICINES MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA CAT MEDICINES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA CAT MEDICINES MARKET SIZE, BY ANESTHETICS, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA CAT MEDICINES MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA CAT MEDICINES MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA CAT MEDICINES MARKET SIZE, BY ENDOCRINE, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA CAT MEDICINES MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 171. ARGENTINA CAT MEDICINES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 172. ARGENTINA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. ARGENTINA CAT MEDICINES MARKET SIZE, BY INJECTABLE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 174. ARGENTINA CAT MEDICINES MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 175. ARGENTINA CAT MEDICINES MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 176. ARGENTINA CAT MEDICINES MARKET SIZE, BY TOPICAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 177. ARGENTINA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 178. ARGENTINA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 179. ARGENTINA CAT MEDICINES MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 180. ARGENTINA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 181. ARGENTINA CAT MEDICINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. ARGENTINA CAT MEDICINES MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY ANESTHETICS, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY ENDOCRINE, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY INJECTABLE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY TOPICAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA CAT MEDICINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 202. UNITED KINGDOM CAT MEDICINES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM CAT MEDICINES MARKET SIZE, BY ANESTHETICS, 2018-2030 (USD MILLION)
TABLE 204. UNITED KINGDOM CAT MEDICINES MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM CAT MEDICINES MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 206. UNITED KINGDOM CAT MEDICINES MARKET SIZE, BY ENDOCRINE, 2018-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM CAT MEDICINES MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 208. UNITED KINGDOM CAT MEDICINES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 210. UNITED KINGDOM CAT MEDICINES MARKET SIZE, BY INJECTABLE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM CAT MEDICINES MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 212. UNITED KINGDOM CAT MEDICINES MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM CAT MEDICINES MARKET SIZE, BY TOPICAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 214. UNITED KINGDOM CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 216. UNITED KINGDOM CAT MEDICINES MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 218. UNITED KINGDOM CAT MEDICINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM CAT MEDICINES MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 220. GERMANY CAT MEDICINES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 221. GERMANY CAT MEDICINES MARKET SIZE, BY ANESTHETICS, 2018-2030 (USD MILLION)
TABLE 222. GERMANY CAT MEDICINES MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 223. GERMANY CAT MEDICINES MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 224. GERMANY CAT MEDICINES MARKET SIZE, BY ENDOCRINE, 2018-2030 (USD MILLION)
TABLE 225. GERMANY CAT MEDICINES MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 226. GERMANY CAT MEDICINES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 227. GERMANY CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 228. GERMANY CAT MEDICINES MARKET SIZE, BY INJECTABLE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 229. GERMANY CAT MEDICINES MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 230. GERMANY CAT MEDICINES MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 231. GERMANY CAT MEDICINES MARKET SIZE, BY TOPICAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 232. GERMANY CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 233. GERMANY CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 234. GERMANY CAT MEDICINES MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 235. GERMANY CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 236. GERMANY CAT MEDICINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. GERMANY CAT MEDICINES MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 238. FRANCE CAT MEDICINES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 239. FRANCE CAT MEDICINES MARKET SIZE, BY ANESTHETICS, 2018-2030 (USD MILLION)
TABLE 240. FRANCE CAT MEDICINES MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 241. FRANCE CAT MEDICINES MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 242. FRANCE CAT MEDICINES MARKET SIZE, BY ENDOCRINE, 2018-2030 (USD MILLION)
TABLE 243. FRANCE CAT MEDICINES MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 244. FRANCE CAT MEDICINES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 245. FRANCE CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 246. FRANCE CAT MEDICINES MARKET SIZE, BY INJECTABLE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 247. FRANCE CAT MEDICINES MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 248. FRANCE CAT MEDICINES MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 249. FRANCE CAT MEDICINES MARKET SIZE, BY TOPICAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 250. FRANCE CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 251. FRANCE CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 252. FRANCE CAT MEDICINES MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 253. FRANCE CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 254. FRANCE CAT MEDICINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. FRANCE CAT MEDICINES MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 256. RUSSIA CAT MEDICINES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 257. RUSSIA CAT MEDICINES MARKET SIZE, BY ANESTHETICS, 2018-2030 (USD MILLION)
TABLE 258. RUSSIA CAT MEDICINES MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 259. RUSSIA CAT MEDICINES MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 260. RUSSIA CAT MEDICINES MARKET SIZE, BY ENDOCRINE, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA CAT MEDICINES MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA CAT MEDICINES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA CAT MEDICINES MARKET SIZE, BY INJECTABLE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA CAT MEDICINES MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA CAT MEDICINES MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA CAT MEDICINES MARKET SIZE, BY TOPICAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA CAT MEDICINES MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 271. RUSSIA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 272. RUSSIA CAT MEDICINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. RUSSIA CAT MEDICINES MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 274. ITALY CAT MEDICINES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 275. ITALY CAT MEDICINES MARKET SIZE, BY ANESTHETICS, 2018-2030 (USD MILLION)
TABLE 276. ITALY CAT MEDICINES MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 277. ITALY CAT MEDICINES MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 278. ITALY CAT MEDICINES MARKET SIZE, BY ENDOCRINE, 2018-2030 (USD MILLION)
TABLE 279. ITALY CAT MEDICINES MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 280. ITALY CAT MEDICINES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 281. ITALY CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 282. ITALY CAT MEDICINES MARKET SIZE, BY INJECTABLE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 283. ITALY CAT MEDICINES MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 284. ITALY CAT MEDICINES MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 285. ITALY CAT MEDICINES MARKET SIZE, BY TOPICAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 286. ITALY CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 287. ITALY CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 288. ITALY CAT MEDICINES MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 289. ITALY CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 290. ITALY CAT MEDICINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 291. ITALY CAT MEDICINES MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 292. SPAIN CAT MEDICINES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 293. SPAIN CAT MEDICINES MARKET SIZE, BY ANESTHETICS, 2018-2030 (USD MILLION)
TABLE 294. SPAIN CAT MEDICINES MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 295. SPAIN CAT MEDICINES MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 296. SPAIN CAT MEDICINES MARKET SIZE, BY ENDOCRINE, 2018-2030 (USD MILLION)
TABLE 297. SPAIN CAT MEDICINES MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 298. SPAIN CAT MEDICINES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 299. SPAIN CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 300. SPAIN CAT MEDICINES MARKET SIZE, BY INJECTABLE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 301. SPAIN CAT MEDICINES MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 302. SPAIN CAT MEDICINES MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 303. SPAIN CAT MEDICINES MARKET SIZE, BY TOPICAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 304. SPAIN CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 305. SPAIN CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 306. SPAIN CAT MEDICINES MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 307. SPAIN CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 308. SPAIN CAT MEDICINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 309. SPAIN CAT MEDICINES MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES CAT MEDICINES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES CAT MEDICINES MARKET SIZE, BY ANESTHETICS, 2018-2030 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES CAT MEDICINES MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES CAT MEDICINES MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES CAT MEDICINES MARKET SIZE, BY ENDOCRINE, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES CAT MEDICINES MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES CAT MEDICINES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES CAT MEDICINES MARKET SIZE, BY INJECTABLE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES CAT MEDICINES MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES CAT MEDICINES MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES CAT MEDICINES MARKET SIZE, BY TOPICAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES CAT MEDICINES MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES CAT MEDICINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES CAT MEDICINES MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 328. SAUDI ARABIA CAT MEDICINES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 329. SAUDI ARABIA CAT MEDICINES MARKET SIZE, BY ANESTHETICS, 2018-2030 (USD MILLION)
TABLE 330. SAUDI ARABIA CAT MEDICINES MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 331. SAUDI ARABIA CAT MEDICINES MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 332. SAUDI ARABIA CAT MEDICINES MARKET SIZE, BY ENDOCRINE, 2018-2030 (USD MILLION)
TABLE 333. SAUDI ARABIA CAT MEDICINES MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 334. SAUDI ARABIA CAT MEDICINES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 335. SAUDI ARABIA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 336. SAUDI ARABIA CAT MEDICINES MARKET SIZE, BY INJECTABLE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 337. SAUDI ARABIA CAT MEDICINES MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 338. SAUDI ARABIA CAT MEDICINES MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 339. SAUDI ARABIA CAT MEDICINES MARKET SIZE, BY TOPICAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 340. SAUDI ARABIA CAT MEDICINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 341. SAUDI ARABIA CAT MEDICINES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 342. SAUDI ARABIA CAT MEDICINES MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 343. SAUDI ARABIA CAT MEDICINES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 344. SAUDI ARABIA CAT MEDICINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 345. SAUDI ARABIA CAT MEDICINES MARKET SIZE, BY VETERINARY PROFESSIONALS, 2018-2030 (USD MILLION)
TABLE 346. SOUTH AFRICA CAT MEDICINES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 347. SOUTH AFRICA CAT MEDICINES MARKET SIZE, BY ANESTHETICS, 2018-2030 (USD MILLION)
TABLE 348. SOUTH AFRICA CAT MEDICINES MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 349. SOUTH AFRICA CAT MEDICINES MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 350. SOUTH AFRICA CAT MEDICINES MARKET SIZE, BY ENDOCRINE, 2018-2030 (USD MILLION)
TABLE 351. SOUTH AFRICA CAT MEDICINES MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 352. SOUTH AFRICA CAT MEDICINES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 353. SOUTH AFRICA CAT MEDICINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 354. SOUTH AFRICA CAT MEDICINES MARKET SIZE, BY INJECTABLE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 355. SOUTH AFRICA CAT MEDICINES MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 356. SOUTH AFRICA CAT MEDICINES MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 357. SOUTH AFRICA CAT MEDICINES MARKET SIZE, BY TOPICAL PRODUCTS, 20

Companies Mentioned

The companies profiled in this Cat Medicines market report include:
  • Zoetis Inc.
  • Boehringer Ingelheim International GmbH
  • Merck & Co., Inc.
  • Elanco Animal Health Incorporated
  • Ceva Santé Animale S.A.
  • Virbac S.A.
  • Vetoquinol S.A.
  • Dechra Pharmaceuticals PLC
  • Phibro Animal Health Corporation
  • Heska Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages192
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 17.19 Billion
Forecasted Market Value ( USD ) by 2030 $ 23.58 Billion
Compound Annual Growth Rate6.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Reports

Companion Animal Pharmaceuticals Market by Animal Type, Product Type, Distribution Channel, Disease Condition, Formulation - Global Forecast to 2030 - Product Image

Companion Animal Pharmaceuticals Market by Animal Type, Product Type, Distribution Channel, Disease Condition, Formulation - Global Forecast to 2030

  • Report
  • 193 Pages
  • Global
From
Traditional Chinese Medicine Formulations for Veterinary Use Market by Animal Type, Dosage Form, Distribution Channel, End User, Application Route - Global Forecast to 2030 - Product Image

Traditional Chinese Medicine Formulations for Veterinary Use Market by Animal Type, Dosage Form, Distribution Channel, End User, Application Route - Global Forecast to 2030

  • Report
  • 190 Pages
  • China, Global
From
Cat Vaccine Market Size, Share & Trends Analysis Report by Vaccine Type (Inactivated), Disease Type, Route of Administration, Duration of Immunity, Component, Region, and Segment Forecasts, 2024-2030 - Product Image

Cat Vaccine Market Size, Share & Trends Analysis Report by Vaccine Type (Inactivated), Disease Type, Route of Administration, Duration of Immunity, Component, Region, and Segment Forecasts, 2024-2030

  • Report
  • 100 Pages
  • Global
From
Veterinary Medicine Market Size, Share & Trends Analysis Report By Product (Biologics, Pharmaceuticals), By Animal Type, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Veterinary Medicine Market Size, Share & Trends Analysis Report By Product (Biologics, Pharmaceuticals), By Animal Type, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 258 Pages
  • Global
From
Veterinary Api Market - Forecasts from 2024 to 2029 - Product Image

Veterinary Api Market - Forecasts from 2024 to 2029

  • Report
  • 145 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.